Target intelligence / Profile preview

5S ribosomal RNA pseudogene 270 (RNA5SP270)

Target
RNA5SP270
Molecular classification
Pseudogene, Processed pseudogene, Ribosomal RNA pseudogene, Non-coding RNA pseudogene
01

Overview

RNA5SP270 is a processed pseudogene derived from the 5S ribosomal RNA gene. Pseudogenes like RNA5SP270 arise through the reverse transcription and genomic integration of RNA copies of functional genes (in this case, the 5S rRNA), but accumulate mutations and are generally non-functional[1][2][4][6][8]. Most 5S rRNA pseudogenes, including RNA5SP270, do not produce functional RNA, do not contribute to ribosome structure or function, and are not implicated in any known human disease or drug response. While some pseudogenes have regulatory or disease relevance, there is no literature supporting a specific biological or medical role for RNA5SP270. Thus, RNA5SP270 is classified as a non-coding, non-functional processed pseudogene and is not a therapeutic target.

Other names
RN5S270RNA, 5S ribosomal 270RNA5SP270
02

Mechanism of action

Not applicable.

03

Biological functions

Most pseudogenes are thought to be non-functional.Some pseudogenes, including certain rRNA pseudogenes, can regulate parental gene expression at the transcriptional and translational levels via RNA-based mechanisms (such as serving as decoys for microRNAs, acting as long non-coding RNAs, or modulating chromatin), but there is no direct evidence that RNA5SP270 specifically performs such functions.
04

Disease associations

Pseudogenes can sometimes play roles in disease, notably as regulators in cancer, but there is *no specific evidence* for RNA5SP270 involvement in any disease.
05

Safety considerations

None known or expected, as it is a non-functional pseudogene without protein or known RNA product.
06

Biomarkers

None known specifically for RNA5SP270. In general, some pseudogene RNAs have been proposed as molecular biomarkers, especially in cancer, but there are no reports implicating RNA5SP270 itself.

Beyond the preview

Go deeper on 5S ribosomal RNA pseudogene 270 (RNA5SP270).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 5S ribosomal RNA pseudogene 270 (RNA5SP270).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call